Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 08 Jun 2026 for Aclaris Therapeutics, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher P. Molineaux: trading record in brief
All filings by Christopher P. Molineaux on record concern Aclaris Therapeutics, Inc., in the capacity of board member. In total, 17 filings cover trades dated from 17 March 2017 to 5 June 2026.
Every open-market trade on record is a sale: 1 sale worth €31k. The rest of the record consists of 16 option exercises.
On 8 June 2026 came the latest disclosure, an option exercise in Aclaris Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Christopher P. Molineaux
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
11,580 sharesCommon StockSEC:0001654773-26-000003:0
4,793 sharesCommon StockSEC:0001415889-25-016247:0
4,660 sharesCommon StockSEC:0001415889-24-015366:0
16,500 shares@ US$1.4199.8% of flowCommon StockSEC:0001209191-23-039080:0
51 shares@ US$0.720.2% of flowCommon StockSEC:0001209191-23-038409:0
4,507 sharesCommon StockSEC:0001209191-23-034455:0
3,356 sharesCommon StockSEC:0001209191-22-034596:0
7 of 7 declarations
